Michael P. Phalen, EVP & President, Med Surg at BOSTON SCIENTIFIC CORP (BSX), sold 13,188 shares at $16.44 ($217K) on 2015-02-19, disclosed to the SEC on 2015-02-20.
Scheduled sale ($217k) by EVP & President, Med Surg under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| BSX | SELL | 2017-10-30 | $441K | — | Filing → |
| BSX | SELL | 2017-10-02 | $445K | — | Filing → |
| BSX | SELL | 2017-08-30 | $416K | — | Filing → |